Loading company details...
Latest Form 4 (Nov 10, 2026): Michael Nofi (Chief Financial Officer): Exercise/Conversion of 10,937 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Michael Nofi, Chief Financial Officer | Exercise/Conversion | 10,937 | n/a |
| Oct 2, 2026 | Jonathan C. Fox | Grant/Award | 308 | n/a |
| Aug 17, 2026 | Michael Nofi, Chief Financial Officer | Grant/Award | 48,750 | n/a |
| Aug 17, 2026 | Alan J. Russell, Chief Scientific Officer | Grant/Award | 65,000 | n/a |
| Aug 17, 2026 | Behrad Derakhshan, Chief Business Officer | Grant/Award | 100,000 | n/a |
| Aug 14, 2026 | Joanne M. Donovan, CMO | Exercise/Conversion | 5,781 | n/a |
| Aug 14, 2026 | John R. Moore, General Counsel | Exercise/Conversion | 5,781 | n/a |
| Aug 14, 2026 | Kevin Koch, President and CEO | Exercise/Conversion | 17,969 | n/a |
| Jul 17, 2026 | Jonathan D. Root | Grant/Award | 16,377 | n/a |
| Jul 2, 2026 | Alan J. Russell, Chief Scientific Officer | Exercise/Conversion | 130,352 | $58.7K |